SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : BIOMIRA RESEARCH (BIOM)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: chirodoc who wrote ()1/19/2000 11:59:00 PM
From: chirodoc   of 72
 
News that will drive stock

by: moleculemike 1/19/00 5:34 pm
Msg: 13158 of 13202
Over the next 12 months, there are several news releases that are likely to come out, although specific timing is difficult:

1. at anytime, new major partnership
2. any day now, update on recruitment for phase III study began over a year ago; target for 950 patients is June or so.
4. anytime now, announcement of BLP-25 with IL-2 study for lung cancer. This is a highly novel and powerful approach to a common and difficult disease.
5. results from phase 2 studies and bridging study for Theratope can occur at any time really, but the longer we don't hear, the better (because it means patients are surviving longer)
6. new initiatives related to autoimmune diseases. This in itself could drive many companies but is a tertiary focus for BIOM
7. first look at phase 3 data...my best guess is a year and a bit from now...keep in mind that a delay in the first look is ironically a good thing because patients will have had longer to benefit from the active treatment arm vs. the placebo arm....
8. Because BIOM's science and collaborations are so strong, at any time we could hear a completely unexpected announcement of new initiatives, as has occurred in past.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext